324 related articles for article (PubMed ID: 37446251)
1. The Role of Ion Channels in Functional Gastrointestinal Disorders (FGID): Evidence of Channelopathies and Potential Avenues for Future Research and Therapeutic Targets.
Maqoud F; Tricarico D; Mallamaci R; Orlando A; Russo F
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446251
[TBL] [Abstract][Full Text] [Related]
2. Ion channelopathies in functional GI disorders.
Beyder A; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G581-G586. PubMed ID: 27514480
[TBL] [Abstract][Full Text] [Related]
3. The role of the SCN5A-encoded channelopathy in irritable bowel syndrome and other gastrointestinal disorders.
Verstraelen TE; Ter Bekke RM; Volders PG; Masclee AA; Kruimel JW
Neurogastroenterol Motil; 2015 Jul; 27(7):906-13. PubMed ID: 25898860
[TBL] [Abstract][Full Text] [Related]
4. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.
Beyder A; Mazzone A; Strege PR; Tester DJ; Saito YA; Bernard CE; Enders FT; Ek WE; Schmidt PT; Dlugosz A; Lindberg G; Karling P; Ohlsson B; Gazouli M; Nardone G; Cuomo R; Usai-Satta P; Galeazzi F; Neri M; Portincasa P; Bellini M; Barbara G; Camilleri M; Locke GR; Talley NJ; D'Amato M; Ackerman MJ; Farrugia G
Gastroenterology; 2014 Jun; 146(7):1659-1668. PubMed ID: 24613995
[TBL] [Abstract][Full Text] [Related]
5. Kir6.1- and SUR2-dependent KATP overactivity disrupts intestinal motility in murine models of Cantú syndrome.
York NW; Parker H; Xie Z; Tyus D; Waheed MA; Yan Z; Grange DK; Remedi MS; England SK; Hu H; Nichols CG
JCI Insight; 2020 Nov; 5(23):. PubMed ID: 33170808
[TBL] [Abstract][Full Text] [Related]
6. Irritable bowel syndrome patients have SCN5A channelopathies that lead to decreased Na
Strege PR; Mazzone A; Bernard CE; Neshatian L; Gibbons SJ; Saito YA; Tester DJ; Calvert ML; Mayer EA; Chang L; Ackerman MJ; Beyder A; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G494-G503. PubMed ID: 29167113
[TBL] [Abstract][Full Text] [Related]
7. The Modulation of Potassium Channels in the Smooth Muscle as a Therapeutic Strategy for Disorders of the Gastrointestinal Tract.
Currò D
Adv Protein Chem Struct Biol; 2016; 104():263-305. PubMed ID: 27038377
[TBL] [Abstract][Full Text] [Related]
8. The Pivotal Role of TRP Channels in Homeostasis and Diseases throughout the Gastrointestinal Tract.
Alaimo A; Rubert J
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652951
[TBL] [Abstract][Full Text] [Related]
9. Pain channelopathies.
Cregg R; Momin A; Rugiero F; Wood JN; Zhao J
J Physiol; 2010 Jun; 588(Pt 11):1897-904. PubMed ID: 20142270
[TBL] [Abstract][Full Text] [Related]
10. Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome.
Fuentes IM; Christianson JA
Neurogastroenterol Motil; 2016 Nov; 28(11):1613-1618. PubMed ID: 27781369
[TBL] [Abstract][Full Text] [Related]
11. Ion channelopathies of the immune system.
Vaeth M; Feske S
Curr Opin Immunol; 2018 Jun; 52():39-50. PubMed ID: 29635109
[TBL] [Abstract][Full Text] [Related]
12. Potassium Channelopathies and Gastrointestinal Ulceration.
Han J; Lee SH; Giebisch G; Wang T
Gut Liver; 2016 Nov; 10(6):881-889. PubMed ID: 27784845
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract.
Szymaszkiewicz A; Włodarczyk J; Wasilewski A; Di Marzo V; Storr M; Fichna J; Zielińska M
Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug; 393(8):1357-1364. PubMed ID: 32002574
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial channelopathies in aging.
Pi Y; Goldenthal MJ; Marín-García J
J Mol Med (Berl); 2007 Sep; 85(9):937-51. PubMed ID: 17426949
[TBL] [Abstract][Full Text] [Related]
15. Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.
Cenac N; Bautzova T; Le Faouder P; Veldhuis NA; Poole DP; Rolland C; Bertrand J; Liedtke W; Dubourdeau M; Bertrand-Michel J; Zecchi L; Stanghellini V; Bunnett NW; Barbara G; Vergnolle N
Gastroenterology; 2015 Aug; 149(2):433-44.e7. PubMed ID: 25911511
[TBL] [Abstract][Full Text] [Related]
16. Ion Transporters, Channelopathies, and Glucose Disorders.
Demirbilek H; Galcheva S; Vuralli D; Al-Khawaga S; Hussain K
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137773
[TBL] [Abstract][Full Text] [Related]
17. Main ion channels and receptors associated with visceral hypersensitivity in irritable bowel syndrome.
de Carvalho Rocha HA; Dantas BP; Rolim TL; Costa BA; de Medeiros AC
Ann Gastroenterol; 2014; 27(3):200-206. PubMed ID: 24976114
[TBL] [Abstract][Full Text] [Related]
18. The traditional herbal medicines mixture, Banhasasim-tang, relieves the symptoms of irritable bowel syndrome via modulation of TRPA1, NaV1.5 and NaV1.7 channels.
Choi NR; Kwon MJ; Choi WG; Kim SC; Park JW; Nam JH; Kim BJ
J Ethnopharmacol; 2023 Aug; 312():116499. PubMed ID: 37059250
[TBL] [Abstract][Full Text] [Related]
19. Colonic overexpression of the T-type calcium channel Ca
Scanzi J; Accarie A; Muller E; Pereira B; Aissouni Y; Goutte M; Joubert-Zakeyh J; Picard E; Boudieu L; Mallet C; Gelot A; Ardid D; Carvalho FA; Dapoigny M
Neurogastroenterol Motil; 2016 Nov; 28(11):1632-1640. PubMed ID: 27196538
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.
Imbrici P; Liantonio A; Camerino GM; De Bellis M; Camerino C; Mele A; Giustino A; Pierno S; De Luca A; Tricarico D; Desaphy JF; Conte D
Front Pharmacol; 2016; 7():121. PubMed ID: 27242528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
